To cap a volatile week, the countries that own the Inter-American Development Bank (IDB) will likely elect a new president—US citizen Mauricio Claver Carone (aka MCC)—from a field of one. Others have parsed the pros and cons of this outcome given the upcoming US election; here, we look at the priorities and reforms that MCC has floated in the media and reflect on their fit vis a vis the challenges in the region.
CGD Policy Blogs
A simple way to guarantee an adequate flow of long-run, sustained funding for health surveillance and disease control, and to prepare for the next novel virus in the world’s poor countries, is to create an endowment dedicated to that purpose. A $10 billion endowment could generate income of $500 million a year.
In 2019, major sources of concessional finance—the big global health funders like the Global Fund and Gavi, as well as the development-bank-based IDA and the African Development Fund—will ask donors for more money to accomplish more health and development.
From the superbug scare in Pennsylvania last month to the UK’s recently released Review on Antimicrobial Resistance, slowing the rate at which infections become resistant to antibiotics is rising up the list of global health priorities—and rightfully so. The Review estimates that deaths from antimicrobial resistance (AMR) could reach 10 million people a year by 2050 if we don’t reduce the overuse and misuse of antimicrobials, including antibiotics, and that the economic damage could add up to a staggering $100 trillion by 2050.